S2312 CARAVAN

Prostate Cancer

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate-resistant Prostate Cancer (MCRPC), Stratified By Aggressive Variant Signature.

Key Team Members

Principal Investigator

Scott Graupner, DO

Research Coordinator

Taylor Knight

Accepting Patients

Enrollment Started: April 29, 2025

About the Trial

The purpose of this study is to compare the usual treatment alone to the usual treatment plus carboplatin.

Get Primary Care

Photo of the Lexington Medical Center hospital campus

Lexington Medical Center

2720 Sunset Blvd.
West Columbia, SC 29169
Google Maps

Hospital Map

Emergency Room

Find More Locations